ArticleMicrobiologyOpen2025
Detection and Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Raw Seafood From the Coastal Area of Bangladesh.
Article in MicrobiologyOpen, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- First Report of blaMicrobiologyOpen · 2026Article
- Unveiling the presence of ESBL-producing coliform bacteria in the aquaculture system of Cumilla District of Bangladesh.New microbes and new infections · 2026Article
- Genome-wide analysis of extended-spectrum beta-lactamase-producingFrontiers in microbiology · 2026Article
- A Comprehensive Review of Antibiotics and Antimicrobial Resistance in the Aquaculture Sector of the World and Bangladesh.International journal of microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The emergence of antimicrobial resistance (AMR) and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (ESBL-EC) in seafood represents a significant public health concern. In this study, we screened 102 raw seafood samples, comprising shrimp (n = 42), sea fish (n = 36), and crabs (n = 24), to detect ESBL-EC. E. coli was isolated and identified through culture-based methods, staining procedures, biochemical assays, and polymerase chain reaction (PCR) analysis. The AMR properties of E. coli isolates were evaluated using the disc diffusion test, while ESBL-EC was identified phenotypically through the double-disc synergy test and confirmed at the genetic level using PCR. PCR analysis revealed that 42.2% (43/102) of the samples were contaminated with E. coli, with sea fish showing the highest (p < 0.05) prevalence (63.9%, 23/36), followed by crabs (37.5%, 9/24) and shrimp (26.2%, 11/42). All the isolates exhibited phenotypic resistance to ampicillin, followed by ceftazidime (95.3%), ciprofloxacin (55.8%), azithromycin (39.5%), cefotaxime (37.2%), and streptomycin (16.3%). Notably, 69.8% (30/43) of E. coli isolates exhibited phenotypically multidrug resistance. Moreover, 18.6% (8/43) of the isolates showed ESBL-producing characteristics, higher in shrimp than in sea fish and crabs. ESBL-related gene, bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.